Meeting
2023 ASCO Annual Meeting
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity.
Authors
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom
Claire Palles , Marie Lucas , Katie Watts , Sara Galavotti , Ik Shin Chin , Cameron Campbell , Sarah E W Briggs , Emma Jaeger , David Church , Karen Taylor , Judith Bliss , David Fisher , Ayman Madi , David A. Cameron , Timothy S. Maughan , Ian Tomlinson , Timothy Iveson , David James Kerr , Rachel Kerr , Jeremy Cheadle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Chemotherapy and Antibody-Drug Conjugates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3028)
DOI
10.1200/JCO.2023.41.16_suppl.3028
Abstract #
3028
Poster Bd #
226
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.
First Author: Kenji Tomizawa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer.
First Author: Akshit Chitkara
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Phase 1b/2, open-label, dose-escalation and expansion trial of tucatinib in combination with trastuzumab with and without oxaliplatin-based chemotherapy or pembrolizumab in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in progress).
First Author: Haeseong Park
Poster
2017 ASCO Annual Meeting
Association between timing and duration of adjuvant chemotherapy and survival for colorectal cancer in korea, 2011-2014: A nationwide study based on the database of quality assessment and the health insurance.
First Author: In Gyu Hwang